Sidney Kahn, M. D., Ph. D.
Sidney Kahn holds an MB, ChB (Cape Town), a Ph. D. (London), specialist
certification by the Royal College of Pathologists, and membership of
the Faculty of Pharmaceutical Medicine, UK. After 17 years in academia,
he spent 13 years at Bristol-Myers Squibb and Johnson & Johnson managing
safety assessment of medicines throughout their lifecycle. He was
actively involved in multiple global pharmacovigilance initiatives, including
several ICH EWGs and the CIOMS-VI WG. His ongoing activities include
the HL7 SPL Implementation WG and DIA SIACs for Labeling, Clinical Safety
and Pharmacovigilance, and Terminology Management. He is currently President
of Pharmacovigilance & Risk Management Inc., a consulting company he founded in 2002. |